The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions
- PMID: 30783005
- PMCID: PMC6496074
- DOI: 10.1128/AAC.02586-18
The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions
Abstract
Recombinant Candida albicans CYP51 (CaCYP51) proteins containing 23 single and 5 double amino acid substitutions found in clinical strains and the wild-type enzyme were expressed in Escherichia coli and purified by Ni2+-nitrilotriacetic acid agarose chromatography. Catalytic tolerance to azole antifungals was assessed by determination of the concentration causing 50% enzyme inhibition (IC50) using CYP51 reconstitution assays. The greatest increase in the IC50 compared to that of the wild-type enzyme was observed with the five double substitutions Y132F+K143R (15.3-fold), Y132H+K143R (22.1-fold), Y132F+F145L (10.1-fold), G307S+G450E (13-fold), and D278N+G464S (3.3-fold). The single substitutions K143R, D278N, S279F, S405F, G448E, and G450E conferred at least 2-fold increases in the fluconazole IC50, and the Y132F, F145L, Y257H, Y447H, V456I, G464S, R467K, and I471T substitutions conferred increased residual CYP51 activity at high fluconazole concentrations. In vitro testing of select CaCYP51 mutations in C. albicans showed that the Y132F, Y132H, K143R, F145L, S405F, G448E, G450E, G464S, Y132F+K143R, Y132F+F145L, and D278N+G464S substitutions conferred at least a 2-fold increase in the fluconazole MIC. The catalytic tolerance of the purified proteins to voriconazole, itraconazole, and posaconazole was far lower and limited to increased residual activities at high triazole concentrations for certain mutations rather than large increases in IC50 values. Itraconazole was the most effective at inhibiting CaCYP51. However, when tested against CaCYP51 mutant strains, posaconazole seemed to be the most resistant to changes in MIC as a result of CYP51 mutation compared to itraconazole, voriconazole, or fluconazole.
Keywords: Candida albicans CYP51; azole; mutations.
Copyright © 2019 Warrilow et al.
Figures





Similar articles
-
Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.J Biochem. 2005 May;137(5):625-32. doi: 10.1093/jb/mvi073. J Biochem. 2005. PMID: 15944416
-
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.Antimicrob Agents Chemother. 2015 Jan;59(1):450-60. doi: 10.1128/AAC.03470-14. Epub 2014 Nov 10. Antimicrob Agents Chemother. 2015. PMID: 25385095 Free PMC article.
-
Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.Antimicrob Agents Chemother. 2018 Feb 23;62(3):e02242-17. doi: 10.1128/AAC.02242-17. Print 2018 Mar. Antimicrob Agents Chemother. 2018. PMID: 29263059 Free PMC article.
-
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.Diagn Microbiol Infect Dis. 2010 Apr;66(4):373-84. doi: 10.1016/j.diagmicrobio.2009.11.006. Diagn Microbiol Infect Dis. 2010. PMID: 20226328 Review.
-
[Azole resistance in Candida spp].Nihon Ishinkin Gakkai Zasshi. 2003;44(2):87-92. doi: 10.3314/jjmm.44.87. Nihon Ishinkin Gakkai Zasshi. 2003. PMID: 12748589 Review. Japanese.
Cited by
-
Exploring Long Arm Amide-Linked Side Chains in the Design of Antifungal Azole Inhibitors of Sterol 14α-Demethylase (CYP51).J Med Chem. 2025 Jun 12;68(11):10781-10799. doi: 10.1021/acs.jmedchem.4c02922. Epub 2025 May 22. J Med Chem. 2025. PMID: 40403151 Free PMC article.
-
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.Drugs. 2021 Oct;81(15):1703-1729. doi: 10.1007/s40265-021-01611-0. Epub 2021 Oct 9. Drugs. 2021. PMID: 34626339 Free PMC article. Review.
-
Azole resistance: patterns of amino acid substitutions in Candida sterol 14α-demethylase.Antonie Van Leeuwenhoek. 2025 Apr 17;118(5):68. doi: 10.1007/s10482-025-02080-1. Antonie Van Leeuwenhoek. 2025. PMID: 40246735
-
Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost.Nat Microbiol. 2024 Nov;9(11):3025-3040. doi: 10.1038/s41564-024-01819-2. Epub 2024 Oct 8. Nat Microbiol. 2024. PMID: 39379635
-
Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51.Front Mol Biosci. 2020 Sep 25;7:586540. doi: 10.3389/fmolb.2020.586540. eCollection 2020. Front Mol Biosci. 2020. PMID: 33102531 Free PMC article.
References
-
- Magill SS, Swoboda SM, Shields CE, Colantuoni EA, Fothergill AW, Merz WG, Lipsett PA, Hendrix CW. 2009. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Ann Surg 249:657–665. doi:10.1097/SLA.0b013e31819ed914. - DOI - PubMed
-
- Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang C-H, Webster KM. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48:1695–1703. doi:10.1086/599039. - DOI - PubMed
-
- Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265–273. doi:10.1086/595846. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources